drugset / Trial / NCT03963336

Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension

NCT03963336

Phase 0 Completed 48 enrolled Fayoum University
RandomizedParallel-groupOpen-labelTreatment

Summary

Idiopathic intracranial hypertension (IIH) is a syndrome characterized by elevated intracranial pressure (ICP) of unknown etiology. The investigators aim to study the quantitative D-dimer level and the role of anticoagulant therapy in the absence of occlusive sinus thrombosis in IIH patients.

Timeline

Start
2017-07-22
Primary completion
2018-07-23
Completion
2018-08-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 1 g
Comparator Acetazolamide Small molecule 2 g
Comparator Heparin Other / unclassified 1 mg/kg Subcutaneous

Indications